NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness.
about
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
NMO-IgG and AQP4 Peptide Can I ...... mune-Mediated Muscle Weakness.
@en
NMO-IgG and AQP4 Peptide Can I ...... mune-Mediated Muscle Weakness.
@nl
type
label
NMO-IgG and AQP4 Peptide Can I ...... mune-Mediated Muscle Weakness.
@en
NMO-IgG and AQP4 Peptide Can I ...... mune-Mediated Muscle Weakness.
@nl
prefLabel
NMO-IgG and AQP4 Peptide Can I ...... mune-Mediated Muscle Weakness.
@en
NMO-IgG and AQP4 Peptide Can I ...... mune-Mediated Muscle Weakness.
@nl
P2093
P2860
P356
P1476
NMO-IgG and AQP4 Peptide Can I ...... mmune-Mediated Muscle Weakness
@en
P2093
Dimitrios Karussis
Livnat Brill
Oded Abramsky
Talma Brenner
Tehila Mizrachi
Yakov Fellig
Yoram Nevo
P2860
P304
P356
10.1155/2018/5389282
P577
2018-05-22T00:00:00Z